CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase 1 Investigation of Belinostat-Based Combinations in Relapsed/Refractory T-Cell Lymphoma
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT07691450
- Title field or adapter rule
- {'original_value': 'Phase 1 Investigation of Belinostat-Based Combinations in Relapsed/Refractory T-Cell Lymphoma', 'source_field': 'protocolSection.identificationModule.officialTitle'}
- Ingested At
- 2026-10-31T23:27:29.413488+00:00
- Published At
- 2026-10-30T00:00:00+00:00
- Record Updated At
- 2026-10-30
- Source Retrieved At
- 2026-10-31T22:18:11.341859+00:00
- Timestamp Basis
- ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
- Date limitation
- ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Recurrent Anaplastic Large Cell Lymphoma", "Recurrent Enteropathy-Associated T-Cell Lymphoma", "Recurrent Follicular Helper T-Cell Lymphoma", "Recurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type", "Recurrent Follicular Helper T-Cell Lymphoma, Follicular-Type", "Recurrent Follicular Helper T-Cell Lymphoma, Not Otherwise Specified", "Recurrent Hepatosplenic T-Cell Lymphoma", "Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma", "Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma", "Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified", "Recurrent Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma", "Recurrent Primary Cutaneous Gamma-Delta T-Cell Lymphoma", "Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma", "Refractory Anaplastic Large Cell Lymphoma", "Refractory Enteropathy-Associated T-Cell Lymphoma", "Refractory Follicular Helper T-Cell Lymphoma", "Refractory Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type", "Refractory Follicular Helper T-Cell Lymphoma, Follicular-Type", "Refractory Follicular Helper T-Cell Lymphoma, Not Otherwise Specified", "Refractory Hepatosplenic T-Cell Lymphoma", "Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma", "Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma", "Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified", "Refractory Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma", "Refractory Primary Cutaneous Gamma-Delta T-Cell Lymphoma", "Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma"]- protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-30", "type": "ACTUAL"}- protocolSection.identificationModule.nctId
"NCT07691450"- protocolSection.identificationModule.officialTitle
"Phase 1 Investigation of Belinostat-Based Combinations in Relapsed/Refractory T-Cell Lymphoma"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct
null
Study condition terms
Interventions recorded in this study
- {'armGroupLabels': ['Arm A (azacitidine, belinostat)'], 'description': 'Given SC', 'name': 'Azacitidine', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Arm A (azacitidine, belinostat)', 'Arm B (pralatrexate, belinostat)'], 'description': 'Given IV', 'name': 'Belinostat', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Arm A (azacitidine, belinostat)', 'Arm B (pralatrexate, belinostat)'], 'description': 'Undergo blood sample collection', 'name': 'Biospecimen Collection', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Arm A (azacitidine, belinostat)', 'Arm B (pralatrexate, belinostat)'], 'description': 'Undergo CT or PET/CT', 'name': 'Computed Tomography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Arm A (azacitidine, belinostat)', 'Arm B (pralatrexate, belinostat)'], 'description': 'Undergo FDG-PET', 'name': 'FDG-Positron Emission Tomography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Arm A (azacitidine, belinostat)', 'Arm B (pralatrexate, belinostat)'], 'description': 'Given FDG', 'name': 'Fludeoxyglucose F-18', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Arm A (azacitidine, belinostat)', 'Arm B (pralatrexate, belinostat)'], 'description': 'Undergo PET/CT', 'name': 'Positron Emission Tomography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Arm B (pralatrexate, belinostat)'], 'description': 'Given SC', 'name': 'Pralatrexate', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Arm A (azacitidine, belinostat)', 'Arm B (pralatrexate, belinostat)'], 'description': 'Ancillary studies', 'name': 'Questionnaire Administration', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])
An intervention appearing in a study record does not establish an effect or an approved use.
Drug names recorded in this source
A recorded drug name is not by itself an indication or a condition-specific relationship.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.